Biogen SG&A Expense (Quarterly) Analysis

Biogen Inc (BIIB)

190.45 -1.71 (-0.89%) USD | NASDAQ | Apr 18, 16:00

190.00 -0.45 (-0.24%) After-Hours: 04:22

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1989. Upgrade now.

Date	Value
December 31, 2023	608.50M
September 30, 2023	788.20M
June 30, 2023	548.00M
March 31, 2023	605.00M
December 31, 2022	632.80M
September 30, 2022	563.30M
June 30, 2022	572.60M
March 31, 2022	634.90M
December 31, 2021	787.90M
September 30, 2021	654.10M
June 30, 2021	637.30M
March 31, 2021	595.00M
December 31, 2020	806.20M
September 30, 2020	573.10M
June 30, 2020	555.10M
March 31, 2020	570.10M
December 31, 2019	664.90M
September 30, 2019	554.50M
June 30, 2019	587.60M
March 31, 2019	567.70M
December 31, 2018	591.10M
September 30, 2018	497.70M
June 30, 2018	516.20M
March 31, 2018	501.30M
December 31, 2017	572.00M

Date	Value
September 30, 2017	433.40M
June 30, 2017	429.80M
March 31, 2017	498.70M
December 31, 2016	494.20M
September 30, 2016	462.70M
June 30, 2016	492.40M
March 31, 2016	497.30M
December 31, 2015	583.00M
September 30, 2015	477.80M
June 30, 2015	491.90M
March 31, 2015	560.40M
December 31, 2014	573.57M
September 30, 2014	570.44M
June 30, 2014	576.62M
March 31, 2014	511.67M
December 31, 2013	522.91M
September 30, 2013	405.58M
June 30, 2013	431.01M
March 31, 2013	352.60M
December 31, 2012	375.98M
September 30, 2012	299.63M
June 30, 2012	301.77M
March 31, 2012	300.09M
December 31, 2011	39.60M
September 30, 2011	342.87M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

548.00M

Minimum

Jun 2023

806.20M

Maximum

Dec 2020

628.37M

Average

605.00M

Median

Mar 2023

SG&A Expense (Quarterly) Benchmarks